Xeno-Skin

N/A

Report date: 2025/05/14 18:14:08

Base Information

Drug NameXeno-Skin

Drug Alias NameGenetically engineered (alpha-1,3-galactosyltransferase knock-out}, live cell porcine (Sus scrofa) xenotransplantation skin graftNon-autologous, living skin transplant（Alexis Bio）realSKIN

ClassificationBiologics

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsBurnsWounds and InjuriesOropharyngeal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesXenotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesXeno Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsBurnsOropharyngeal Neoplasms

Inactive IndicationsWounds and Injuries

Other Information

ATC CodeN/A